Hints and tips:
...This could also include in our view Wyeth’s consumer healthcare business or Schering Plough’s consumer health care business....
...Fred Hassan, head of Schering-Plough, which recently agreed a $48bn takeover by Merck, says: “We were in line with our strategic plan and doing well with good growth, but the changes in the macro-environment...
..., president and CEOSince 2006, previously Alcan Packaging president and CEO Carrie Cox, Schering-Plough Global Pharmaceuticals president and EVP Deidre Connelly, GSK North American Pharmaceuticals presidentSince...
...“GSK should focus on drug development,” says a large shareholder in the company. “If it demerged its consumer healthcare business, it could crystallise a company with two times the multiple.”...
...In 1997, Schering had ended a long-running legal dispute over one of its patents by paying Upsher $60m to withhold sales of a generic version of K-Dur 20, a Schering supplement that treats the side-effects...
...FT: Is Schering-Plough still a non-starter as far as taking them over? DC: Yes. FT: You’re happy with the joint venture? A: We have a great relationship....
International Edition